Research Output per year
Research Output 1965 2017
- 1 - 50 out of 490 results
- Title (ascending)
Ability of cell-sized beads bearing tumor cell membrane proteins to stimulate LAK cells to secrete interferon-γ and tumor necrosis factor-α1
Chong, A. S. F., Pinkard, J. K., Lam, K. S., Scuderi, P., Hersh, E. M. & Grimes, W. J., Apr 15 1991, In : Cellular Immunology. 134, 1, p. 96-110 15 p.Research output: Contribution to journal › Article
Abnormal lymphocyte response to exogenous interleukin-2 in homosexuals with acquired immune deficiency syndrome (AIDS) and AIDS related complex (ARC)
Murray, J. L., Hersh, E. M., Reuben, J. M., Munn, C. G. & Mansell, P. W., 1985, In : Clinical and Experimental Immunology. 60, 1, p. 25-30 6 p.Research output: Contribution to journal › Article
Acquired immune deficiency syndrome: A new clinical entity
Hersh, E. M. & Mansell, P. W. A., Apr 1983, In : Clinical Immunology Newsletter. 4, 4, p. 39-43 5 p.Research output: Contribution to journal › Article
Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma
Robidoux, A., Gutterman, J. U., Bodey, G. P. & Hersh, E. M., 1982, In : Cancer. 49, 11, p. 2246-2251 6 p.Research output: Contribution to journal › Article
Activation of cyclic nucleotide phosphodiesterase from isolated human peripheral blood lymphocytes by mitogenic agents
Epstein, P. M., Mills, J. S., Hersh, E. M., Strada, S. J. & Thompson, W. J., 1980, In : Cancer Research. 40, 2, p. 379-386 8 p.Research output: Contribution to journal › Article
Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine
Thompson, W. J., Ross, C. P., Hersh, E. M., Epstein, P. M. & Strada, S. J., 1980, In : Journal of Cyclic Nucleotide Research. 6, 1, p. 25-36 12 p.Research output: Contribution to journal › Article
ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMA
Gutterman, J. U., McBride, C., Freireich, E. J., Mavligit, G., Frei, E. & Hersh, E. M., Jun 2 1973, In : The Lancet. 301, 7814, p. 1208-1212 5 p.Research output: Contribution to journal › Article
Active specific immunization with allogeneic leukemia associated antigens or irradiated allogeneic leukemia cells in acute leukemia
Ezaki, K., Hersh, E. M., Keating, M., Dyre, S., Hollinshead, A., McCredie, K. B., Mavlight, G. M. & Gutterman, J. U., 1978, In : Cancer. 41, 1, p. 70-83 14 p.Research output: Contribution to journal › Article
Acute leukemia in adults, 1977
Keating, M. J., Freireich, E. J., McCredie, K. B., Bodey, G. P., Hersh, E. M., Hester, J. P., Rodriguez, V. & Hart, J., 1977, In : CA Cancer Journal for Clinicians. 27, 1, p. 2-25 24 p.Research output: Contribution to journal › Article
Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED).
Buzdar, A. U., Blumenschein, G. R., Smith, T. L., Tashima, C. K., Hortobagyi, G. N., Yap, H. Y., Gutterman, J. U., Hersh, E. M. & Gehan, E. A., 1979, In : Journal of Surgical Oncology. 12, 1, p. 27-40 14 p.Research output: Contribution to journal › Article
Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette‐Guerin and with or without irradiation in operable breast cancer a prospective randomized trial
Buzdar, A. U., Blumenschein, G. R., Smith, T. L., Powell, K. C., Hortobagyi, G. N., Yap, H. Y., Schell, F. C., Barnes, B. C., Ames, F. C., Martin, R. G. & Hersh, E. M., 1984, In : Cancer. 53, 3, p. 384-389 6 p.Research output: Contribution to journal › Article
Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer (Dukes' class C). Prolongation of disease‐free interval and survival
Mavligit, G. M., Gutterman, J. U., Malahy, M. A., Burgess, M. A., McBride, C. M., Jubert, A. & Hersh, E. M., 1977, In : Cancer. 40, 5 S, p. 2726-2730 5 p.Research output: Contribution to journal › Article
Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer of the Dukes C classification. Preliminary clinical results
Mavligit, G. M., Gutterman, J. U., Burgess, M. A., Khankhanian, N., Seibert, G. B., Speer, J. F., Reed, R. C., Jubert, A. V., Martin, R. C., McBride, C. M., Copeland, E. M., Gehan, E. A. & Hersh, E. M., 1975, In : Cancer. 36, 6 sup., p. 2421-2427 7 p.Research output: Contribution to journal › Article
Administration of BCG cell wall skeleton into malignant effusions: Toxic and therapeutic effects
Richman, S. P., Hersh, E. M., Gutterman, J. U., Hortobagyi, G. N., Blumenschein, G. R., Rios, A. & Ribi, E., 1981, In : Cancer Treatment Reports. 65, 5-6, p. 383-387 5 p.Research output: Contribution to journal › Article
Advances in the biological therapy and gene therapy of malignant disease
Hersh, E. M. & Stopeck, A. T., Dec 1997, In : Clinical Cancer Research. 3, 12 II, p. 2623-2629 7 p.Research output: Contribution to journal › Article
A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia
Keating, M. J., Smith, T. L., McCredie, K. B., Bodey, G. P., Hersh, E. M., Gutterman, J. U., Gehan, E. & Freireich, E. J., 1981, In : Cancer. 47, 12, p. 2779-2788 10 p.Research output: Contribution to journal › Article
A human monoclonal antimelanoma single-chain Fv antibody derived from tumor-infiltrating lymphocytes
Zhang, H., Lake, D. F., Barbuto, J. A. M., Bernstein, R. M., Grimes, W. J. & Hersh, E. M., 1995, In : Cancer Research. 55, 16, p. 3584-3591 8 p.Research output: Contribution to journal › Article
A hybridoma producing human monoclonal antibody specific for glycoprotein 120kDa of human immunodeficiency virus (HIV-1)
Lake, D., Sugano, T., Matsumoto, Y. I., Masuho, Y., Petersen, E. A., Feorino, P. & Hersh, E. M., 1989, In : Life Sciences. 45, 16Research output: Contribution to journal › Article
Alpha interferon for induction of remission in hairy-cell leukemia
Quesada, J. R., Reuben, J., Manning, J. T., Hersh, E. M. & Gutterman, J. U., 1984, In : New England Journal of Medicine. 310, 1, p. 15-18 4 p.Research output: Contribution to journal › Article
Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma
Blumenschein, G. R., Hortobagyi, G. N., Richman, S. P., Gutterman, J. U., Tashima, C. K., Buzdar, A. U., Burgess, M. A., Livingston, R. B. & Hersh, E. M., 1980, In : Cancer. 45, 4, p. 742-749 8 p.Research output: Contribution to journal › Article
Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon
Lotzova, E., Savary, C. A., Quesada, J. R., Gutterman, J. U. & Hersh, E. M., 1983, In : Journal of the National Cancer Institute. 71, 5, p. 903-910 8 p.Research output: Contribution to journal › Article
Analysis of the antitumor agent Bay i 7433 (copovithane) in plasma and urine by high performance liquid chromatography
Rosenblum, M. G., Hersh, E. M., Wingender, W. & Hersh, E. M., 1984, In : Journal of Liquid Chromatography. 7, 1, p. 159-166 8 p.Research output: Contribution to journal › Article
Anergy in cancer
Hersh, E. M., Gutterman, J. U. & Mavligit, G. M., 1976, In : International Journal of Dermatology. 15, 2, p. 112-120 9 p.Research output: Contribution to journal › Article
A new type of synthetic peptide library for identifying ligand-binding activity
Lam, K. S., Salmon, S. E., Hersh, E. M., Hruby, V. J., Kazmierskit, W. M. & Knappt, R. J., Nov 7 1991, In : Nature. 354, 6348, p. 82-84 3 p.Research output: Contribution to journal › Article
An in vivo model of human multidrug-resistant multiple myeloma in SCID mice
Bellamy, W. T., Odeleye, A., Finley, P., Huizenga, B., Dalton, W. S., Weinstein, R. S., Hersh, E. M. & Grogan, T. M., Mar 1993, In : American Journal of Pathology. 142, 3, p. 691-698 8 p.Research output: Contribution to journal › Article
Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patients
Minden, P., Jarrett, C., Mcclatchy, J. K., Gutterman, J. U. & Hersh, E. M., 1976, In : Nature. 263, 5580, p. 774-777 4 p.Research output: Contribution to journal › Article
Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro
Robinson, W. E., Kawamura, T., Lake, D., Masuho, Y., Mitchell, W. M. & Hersh, E. M., 1990, In : Journal of Virology. 64, 11, p. 5301-5305 5 p.Research output: Contribution to journal › Article
Antibodies to tumor necrosis factor: a component of B cell immune responses with a role in tumor/host interaction
Barbuto, J. A. M., Grimes, W. J. & Hersh, E. M., Jan 1995, In : Cancer Immunology, Immunotherapy. 40, 1, p. 31-36 6 p.Research output: Contribution to journal › Article
Antibody-dependent cell-mediated cytotoxicity in human cancer. Characterization of patient leukocyte activity and treatment effects
Hersh, E. M., Murphy, S. G., Gutterman, J. U., Morgan, J., Quesada, J., Zander, A. & Stewart, D., 1982, In : Cancer. 49, 2, p. 251-260 10 p.Research output: Contribution to journal › Article
Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells
Savage, H. E., Rossen, R. D., Hersh, E. M., Freedman, R. S., Bowen, J. M. & Plager, C., 1986, In : Cancer Research. 46, 4 II, p. 2127-2133 7 p.Research output: Contribution to journal › Article
Antibody responses of remission leukemia patients receiving active specific and nonspecific immunotherapy
Granatek, C. H., Ezaki, K., Hersh, E. M., Keating, M. J. & Rasmussen, S., 1981, In : Cancer. 47, 2, p. 272-279 8 p.Research output: Contribution to journal › Article
Antigen dose in the human immune response. Dose-response relationships in the human immune response to Keyhole limpet hemocyanin
Curtis, J. E., Hersh, E. M., Butler, W. T. & Rossen, R. D., 1971, In : The Journal of Laboratory and Clinical Medicine. 78, 1, p. 61-69 9 p.Research output: Contribution to journal › Article
Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast
Coronella, J. A., Perry, C. S., Welch, M., Trevor, K. T., Stopeck, A. T., Villar, H. & Hersh, E. M., Aug 15 2002, In : Journal of Immunology. 169, 4, p. 1829-1836 8 p.Research output: Contribution to journal › Article
Antigen expression and cell surface properties of human leukemic blasts
Cotropia, J. P., Gutterman, J. U. & Hersh, E. M., 1976, In : Annals of the New York Academy of Sciences. Vol. 276, p. 146-164 19 p.Research output: Contribution to journal › Article
Antigen solubilized from human leukemia: Lymphocyte stimulation
Gutterman, J. U., Mavligit, G., McCredie, K. B., Bodey, G. P., Freireich, E. J. & Hersh, E. M., 1972, In : Science. 177, 4054, p. 1114-1115 2 p.Research output: Contribution to journal › Article
Antigen-specific immunity in recipients of leukocyte transfusions from immune donors.
Curtis, J. E., Hersh, E. M. & Freireich, E. J., Dec 1970, In : Cancer Research. 30, 12, p. 2921-2929 9 p.Research output: Contribution to journal › Article
Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro
Hersh, E. M., Gschwind, C. R., Taylor, C. W., Dorr, R. T., Taetle, R. & Salmon, S. E., Aug 19 1992, In : Journal of the National Cancer Institute. 84, 16, p. 1238-1244 7 p.Research output: Contribution to journal › Article
Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes
Punt, C. J. A., Barbuto, J. A. M., Zhang, H., Grimes, W. J., Hatch, K. D. & Hersh, E. M., Jul 1994, In : Cancer Immunology, Immunotherapy. 38, 4, p. 225-232 8 p.Research output: Contribution to journal › Article
A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma
Weber, J. S., Samlowski, W. E., Gonzalez, R., Ribas, A., Stephenson, J., O'Day, S., Sato, T., Dorr, R. T., Grenier, K. & Hersh, E. M., Aug 1 2010, In : Cancer. 116, 15, p. 3683-3691 9 p.Research output: Contribution to journal › Article
A phase 2 clinical trial of nab-Paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma
Hersh, E. M., O'Day, S. J., Ribas, A., Samlowski, W. E., Gordon, M. S., Shechter, D. E., Clawson, A. A. & Gonzalez, R., Jan 1 2010, In : Cancer. 116, 1, p. 155-163 9 p.Research output: Contribution to journal › Article
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma
Cohen, S. J., Zalupski, M. M., Conkling, P., Nugent, F., Ma, W. W., Modiano, M., Pascual, R., Lee, F. C., Wong, L. & Hersh, E. M., Dec 24 2015, (Accepted/In press) In : American Journal of Clinical Oncology: Cancer Clinical Trials.Research output: Contribution to journal › Article
A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors
Taylor, C. W., Dorr, R. T., Fanta, P., Hersh, E. M. & Salmon, S. E., 2001, In : Cancer Chemotherapy and Pharmacology. 47, 1, p. 83-88 6 p.Research output: Contribution to journal › Article
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
Hersh, E. M., O'Day, S. J., Powderly, J., Khan, K. D., Pavlick, A. C., Cranmer, L. D., Samlowski, W. E., Nichol, G. M., Yellin, M. J. & Weber, J. S., Jun 2011, In : Investigational New Drugs. 29, 3, p. 489-498 10 p.Research output: Contribution to journal › Article
A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: A southwest oncology group study
Brown, T. D., Goodman, P., Fleming, T., Macdonald, J. S., Hersh, E. M. & Braun, T. J., 1991, In : Journal of Immunotherapy. 10, 5, p. 376-378 3 p.Research output: Contribution to journal › Article
A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: A Southwest Oncology Group Study
Whitehead, R. P., Fleming, T., Macdonald, J. S., Goodman, P. J., Neefe, J., Braun, T. J., Swinnen, L. J. & Hersh, E. M., 1990, In : Journal of Biological Response Modifiers. 9, 6, p. 588-591 4 p.Research output: Contribution to journal › Article
A Phase II Trial of Vinorelbine Tartrate in Patients with Disseminated Malignant Melanoma and One Prior Systemic Therapy: A Southwest Oncology Group Study
Whitehead, R. P., Moon, J., McCachren, S. S., Hersh, E. M., Samlowski, W. E., Beck, J. T., Tchekmedyian, N. S. & Sondak, V. K., Apr 15 2004, In : Cancer. 100, 8, p. 1699-1704 6 p.Research output: Contribution to journal › Article
A phase i study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer
Cohen, S. J., Zalupski, M. M., Modiano, M. R., Conkling, P., Patt, Y. Z., Davis, P., Dorr, R. T., Boytim, M. L. & Hersh, E. M., Jul 2010, In : Cancer Chemotherapy and Pharmacology. 66, 2, p. 287-294 8 p.Research output: Contribution to journal › Article
A phase I study of intravenous azimexon therapy in human cancer
Patt, Y. Z., Hersh, E. M., Reuben, J., Claghorn, L. & Mavligit, G., 1986, In : Journal of Biological Response Modifiers. 5, 4, p. 313-318 6 p.Research output: Contribution to journal › Article
A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors
Ebbinghaus, S., Rubin, E., Hersh, E. M., Cranmer, L. D., Bonate, P. L., Fram, R. J., Jekunen, A., Weitman, S. & Hammond, L. A., Nov 1 2005, In : Clinical Cancer Research. 11, 21, p. 7807-7816 10 p.Research output: Contribution to journal › Article
A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
Rifkin, R. M., Hersh, E. M. & Salmon, S. E., Aug 1988, In : Behring Institute Mitteilungen. 83, p. 125-133 9 p.Research output: Contribution to journal › Article